GILL DAVID N (CIK 1106519) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-19). Recent activity: Buy EOLS (45,559 shares), Sell YMAB (5,825 shares), Sell YMAB (25,080 shares), Buy YMAB (25,080 shares), Buy EOLS (7,364 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-19 | Evolus, Inc. (EOLS) | Director | Buy | 45,559 | $0 |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 5,825 | $50,095 |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 25,080 | $0 |
| 2025-07-02 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Buy | 25,080 | $0 |
| 2025-03-11 | Evolus, Inc. (EOLS) | Director | Buy | 7,364 | $0 |
Source: SEC Form 4 filings · as of 2026-02-19